ArticleInternational journal of retina and vitreous2025
Smartphone-based retinal camera modified for ROP screening.
Article in International journal of retina and vitreous, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRetinopathy of prematurity (ROP) is a leading cause of preventable childhood blindness worldwide, particularly affecting infants in resource-limited settings. Although indirect binocular ophthalmoscopy (IBO) is considered the definitive method for ROP screening, its broad adoption is restricted by the scarcity of skilled professionals and the practical difficulties involved in performing exams at the patient’s bedside. Smartphone-based retinal imaging is emerging as a viable, low-cost alternative for telemedicine-based ROP screening in underserved regions.
methodsThis cross-sectional study was conducted from June 2022 to December 2023 in a Brazilian tertiary hospital. Preterm infants (GA ≤ 32 weeks and/or BW ≤ 1500 g) underwent standard ROP screening using IBO and a modified smartphone-based retinal camera (Phelcom Eyer®). Images of five retinal fields per eye were acquired by a single examiner, both with and without scleral indentation, which was performed when necessary to visualize the peripheral retina. A masked retina specialist graded image quality and classified ROP stages. Sensitivity, specificity, predictive values, and agreement with IBO (Cohen’s kappa) were calculated.
resultsSeventy-one preterm infants (142 eyes) were included. ROP was diagnosed in 14 infants (19.7%), with six requiring treatment. Among the 337 images obtained, 69% were rated as excellent and 31% as acceptable; all were gradable. Compared to IBO, the device demonstrated a sensitivity of 82.0% and specificity of 100.0% without scleral indentation. When indentation was used—selectively, to improve visualization of Zone III—sensitivity increased to 91.3% and the negative predictive value to 98.3%. Agreement between methods was almost perfect (κ = 0.94). Only one transient episode of bradycardia occurred during indentation.
conclusionsThe modified Phelcom Eyer® camera demonstrated high diagnostic performance for ROP screening, particularly when complemented by selective scleral indentation to enhance peripheral retinal assessment. Its portability, affordability, and integration with telemedicine platforms make it a valuable tool for expanding ROP screening in resource-limited settings with restricted access to specialists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.